• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI Webinar - Introduction to FDA’s MedWatch Adverse Reporting Program - January 14, 2014

The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is again delighted to present a series of educational webinars targeting the needs of all Healthcare Professionals, Pharmacy students, Nurse Practitioner students, Physician Assistant and Medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation. 

These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, nurses, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency. 

On January 14, 2014, CDER’s Office of Communication, Division of Drug Information (DDI) hosted a webinar titled, “Introduction to FDA’s MedWatch and Adverse Event Reporting”. The featured speaker, Anna M. Fine Pharm.D., MS, Director, Health Professional Liaison Program in FDA’s Office of Health and Constituent Affairs gave an overview of the program, how to report adverse events to FDA MedWatch, and where to find clinically relevant information from MedWatch. 

This was Part 1 of 2 Webinars with information on Safety Reporting. Part 2 will be held on February 11, 2014. 

 

 

Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.